EG20380A - Enhanced skin penetration system for improved topical delivery of drugs - Google Patents

Enhanced skin penetration system for improved topical delivery of drugs

Info

Publication number
EG20380A
EG20380A EG62592A EG62592A EG20380A EG 20380 A EG20380 A EG 20380A EG 62592 A EG62592 A EG 62592A EG 62592 A EG62592 A EG 62592A EG 20380 A EG20380 A EG 20380A
Authority
EG
Egypt
Prior art keywords
drugs
skin penetration
topical delivery
penetration system
enhanced skin
Prior art date
Application number
EG62592A
Other languages
English (en)
Inventor
George Endel Deckner
Brian Scott Lombardo
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Application granted granted Critical
Publication of EG20380A publication Critical patent/EG20380A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/04Preparations for care of the skin for chemically tanning the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8158Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54Polymers characterized by specific structures/properties
    • A61K2800/542Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5426Polymers characterized by specific structures/properties characterized by the charge cationic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EG62592A 1991-10-16 1992-10-05 Enhanced skin penetration system for improved topical delivery of drugs EG20380A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77842291A 1991-10-16 1991-10-16
US94839192A 1992-09-25 1992-09-25

Publications (1)

Publication Number Publication Date
EG20380A true EG20380A (en) 1999-02-28

Family

ID=27119450

Family Applications (1)

Application Number Title Priority Date Filing Date
EG62592A EG20380A (en) 1991-10-16 1992-10-05 Enhanced skin penetration system for improved topical delivery of drugs

Country Status (22)

Country Link
US (1) US6277892B1 (es)
EP (1) EP0608322B1 (es)
JP (1) JP3471354B2 (es)
KR (1) KR100264180B1 (es)
CN (1) CN1050763C (es)
AT (1) ATE168563T1 (es)
AU (1) AU675212B2 (es)
BR (1) BR9206631A (es)
CA (1) CA2117265C (es)
CZ (1) CZ90194A3 (es)
DE (1) DE69226369T2 (es)
DK (1) DK0608322T3 (es)
EG (1) EG20380A (es)
ES (1) ES2118834T3 (es)
FI (1) FI941770A0 (es)
GR (1) GR3027757T3 (es)
HK (1) HK1013002A1 (es)
HU (1) HUT67046A (es)
MX (1) MX9205937A (es)
NO (1) NO941317L (es)
NZ (1) NZ244743A (es)
WO (1) WO1993007903A1 (es)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA22677A1 (fr) * 1991-10-16 1993-07-01 Richardson Vicks Inc Compositions cosmetiques en gels
WO1993007902A1 (en) * 1991-10-16 1993-04-29 Richardson-Vicks, Inc. Enhanced skin penetration system for improved topical delivery of drugs
ATE152630T1 (de) * 1992-07-28 1997-05-15 Procter & Gamble Pharmazeutische zusammensetzung zur topischen anwendung die ein vernetztes kationisches polymer und einen alkoxylierte äther enthält
ES2111923T3 (es) * 1993-04-16 1998-03-16 Procter & Gamble Composiciones para impartir un bronceado artificial y proteger la piel de la radiacion ultravioleta.
CA2168543A1 (en) * 1993-07-03 1995-02-09 George Endel Deckner Personal cleansing compositions
US5989536A (en) * 1993-07-03 1999-11-23 The Procter & Gamble Company Personal cleansing compositions containing alkoxylated ether and cationic ammonium salt for deposition of active agent upon the skin
ZA947912B (en) * 1993-10-12 1995-05-24 Broadbent J W Nominees Pty Ltd Treatment of medical disorders associated with free radical formation
US5425938A (en) * 1994-01-28 1995-06-20 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Polyamino salts of alpha-hydroxyacids, alpha-ketoacids and related compounds
ES2153026T5 (es) * 1994-02-18 2004-05-16 Unilever N.V. Composiciones de lavado personal.
AU703926B2 (en) * 1994-03-28 1999-04-01 Trustees Of Columbia University In The City Of New York, The Composition for inactivating irritants in fluids
FR2719475B1 (fr) * 1994-05-05 1996-06-07 Oreal Composition cosmétique et/ou dermatologique à gélifiant polymérique cationique, ses utilisations notamment pour la dépigmentation de la peau.
US5874463A (en) 1994-10-24 1999-02-23 Ancira; Margaret Hydroxy-kojic acid skin peel
US6623744B2 (en) 1995-06-22 2003-09-23 3M Innovative Properties Company Stable hydroalcoholic compositions
EP1374847A1 (en) * 1995-06-22 2004-01-02 Minnesota Mining And Manufacturing Company Stable hydroalcoholic compositions
EP0833606B1 (en) * 1995-06-22 2003-10-01 Minnesota Mining And Manufacturing Company Stable hydroalcoholic compositions
US5759524A (en) * 1996-02-09 1998-06-02 The Procter & Gamble Company Photoprotective compositions
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US7094422B2 (en) 1996-02-19 2006-08-22 Acrux Dds Pty Ltd. Topical delivery of antifungal agents
SE9601528D0 (sv) 1996-04-23 1996-04-23 Pharmacia Ab Transdermally administered dextromethorphan as antitissue agent
US6133281A (en) * 1996-10-24 2000-10-17 Harbor-Ucla Research And Education Institute NMDA receptor blockers in the therapy of urogenital disease
US6019997A (en) * 1997-01-09 2000-02-01 Minnesota Mining And Manufacturing Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents
US6582711B1 (en) * 1997-01-09 2003-06-24 3M Innovative Properties Company Hydroalcoholic compositions thickened using polymers
US5908619A (en) * 1997-01-09 1999-06-01 Minnesota Mining And Manufacturing Company Hydroalcoholic compositions thickened using surfactant/polymer complexes
US20020006913A1 (en) * 1997-11-04 2002-01-17 Von Borstel Reid W. Antimutagenic compositions for treatment and prevention of photodamage to skin
US7752129B2 (en) 1998-10-21 2010-07-06 Island Intellectual Property Llc Systems and methods for managing client accounts
MXPA00006196A (es) * 1998-10-23 2003-07-21 Idea Ag Metodo para desarrollar, evaluar y utilizar asociaciones de macromoleculas y agregados complejos para obtener mejores tasas de asociacion/desasociacion controlable y carga efectiva.
ES2173678T3 (es) 1999-01-27 2002-10-16 Idea Ag Vacunacion no invasiva a traves de la piel.
ES2173679T3 (es) 1999-01-27 2002-10-16 Idea Ag Inmunizacion/transporte transnasal con vehiculos altamente adaptables.
DE19904801A1 (de) * 1999-02-05 2000-08-10 Klossner Axel Mittel zur topischen Behandlung von Hauterkrankungen
MXPA02000053A (es) * 1999-07-05 2003-07-21 Idea Ag Un metodo para mejorar el tratamiento a traves de barreras adaptables semipermeables.
GB0010757D0 (en) 2000-05-05 2000-06-28 Astrazeneca Ab Chemical compounds
WO2002078655A2 (en) * 2001-03-30 2002-10-10 L'oreal Heat activated durable conditioning compositions comprising saccharides and methods for using the same
WO2002102390A1 (en) * 2001-06-18 2002-12-27 Noven Pharmaceuticals, Inc. Enhanced drug delivery in transdermal systems
GB0121941D0 (en) 2001-09-11 2001-10-31 Astrazeneca Ab Chemical compounds
US6805878B2 (en) 2001-09-13 2004-10-19 Noven Pharmaceuticals, Inc. Transdermal administration of ACE inhibitors
US7005031B2 (en) 2002-01-16 2006-02-28 3M Innovative Properties Company Pressure sensitive adhesives having quaternary ammonium functionality, articles, and methods
US7879365B2 (en) 2002-02-07 2011-02-01 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of dermal and mucosal irritation
EP1480517A4 (en) 2002-02-07 2007-08-22 Univ Columbia ZINC SALT COMPOSITIONS FOR PREVENTING MOLECULAR BREAST EXTRACTION THROUGH SPERMICIDES AND MICROBICIDES
US20030232094A1 (en) * 2002-06-12 2003-12-18 Fuller Peter E. Composition and method for the treatment of skin irritations
AU2003251875A1 (en) * 2002-07-15 2004-02-02 Combinatorx, Incorporated Combination therapy for the treatment of neoplasms
US7473432B2 (en) * 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
US20040126339A1 (en) * 2002-12-31 2004-07-01 Roszell James A. Sunscreen composition and methods for manufacturing and using a sunscreen composition
DE10308852A1 (de) * 2003-02-27 2004-09-09 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Mittel gegen Faltenbildung der Haut
US7285576B2 (en) * 2003-03-12 2007-10-23 3M Innovative Properties Co. Absorbent polymer compositions, medical articles, and methods
US7871649B2 (en) 2003-07-17 2011-01-18 The Trustees Of Columbia University In The City Of New York Antimicrobial compositions containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof
US20060229258A1 (en) * 2003-07-30 2006-10-12 Daniela Serikaku Steroidal compositions containing hydroxycarboxylic acids and methods of using the same
US20050123621A1 (en) * 2003-12-05 2005-06-09 3M Innovative Properties Company Silver coatings and methods of manufacture
US20050123590A1 (en) * 2003-12-05 2005-06-09 3M Innovative Properties Company Wound dressings and methods
US7745509B2 (en) * 2003-12-05 2010-06-29 3M Innovative Properties Company Polymer compositions with bioactive agent, medical articles, and methods
CN100411692C (zh) * 2004-01-13 2008-08-20 北京康倍得医药技术开发有限公司 丙烯酸基粘合剂组合物及其药物组合物和透皮治疗系统
KR101147147B1 (ko) * 2004-04-01 2012-05-25 머크 샤프 앤드 돔 코포레이션 Rna 간섭의 오프 타겟 효과 감소를 위한 변형된폴리뉴클레오타이드
US20060035039A1 (en) * 2004-08-12 2006-02-16 3M Innovative Properties Company Silver-releasing articles and methods of manufacture
US20060045858A1 (en) * 2004-08-26 2006-03-02 Fuller Peter E Composition and method for reducing harmful effects of ultraviolet radiation impinging on the skin
CA2584475A1 (en) * 2004-11-12 2006-05-18 Idea Ag Extended surface aggregates in the treatment of skin conditions
SI1856237T1 (sl) * 2005-03-10 2020-12-31 Obagi Cosmeceuticals Llc Stabilne organske sestave peroksida
KR20070115939A (ko) * 2005-03-10 2007-12-06 제이알 켐, 엘엘씨 벤조일 퍼옥사이드 조성물 및 이용 방법
AR054336A1 (es) * 2005-03-30 2007-06-20 Astion Dev As Tratamiento de enfermedades dermatologicas y del prurito
US8399027B2 (en) * 2005-04-14 2013-03-19 3M Innovative Properties Company Silver coatings and methods of manufacture
US20090306023A1 (en) * 2005-06-29 2009-12-10 Ramirez Jose E Stable organic peroxide compositions
US7556820B2 (en) 2005-06-29 2009-07-07 Jr Chem, Llc Stable organic peroxide compositions
WO2007005471A2 (en) * 2005-06-29 2007-01-11 Jr Chem, Llc Stable organic peroxide compositions
US7776339B2 (en) * 2006-01-11 2010-08-17 Active Organics, Lp Extract of R. miehei
US20070166399A1 (en) * 2006-01-13 2007-07-19 3M Innovative Properties Company Silver-containing antimicrobial articles and methods of manufacture
CA2575398C (en) * 2006-02-02 2011-12-20 Omp, Inc. Methods of treating skin to enhance therapeutic treatment thereof
US20100098949A1 (en) * 2006-10-18 2010-04-22 Burton Scott A Antimicrobial articles and method of manufacture
FR2909279B1 (fr) * 2006-11-30 2014-06-13 Oreal Procede de peeling a base de microgel cationique
US7752107B1 (en) 2007-02-28 2010-07-06 Island Intellectual Property Llc System and method for managing aggregated accounts
US8260705B1 (en) 2007-02-28 2012-09-04 Island Intellectual Property Llc Systems, methods and program products for deposit and withdrawal processing
US8032456B1 (en) 2008-02-11 2011-10-04 Island Intellectual Property Llc System, methods and program products for processing for a self clearing broker dealer
US8283314B1 (en) 2007-07-02 2012-10-09 Jan Marini Skin Research, Inc. Skin care compositions
US7915330B2 (en) * 2007-09-06 2011-03-29 Hallstar Innovations Corp. Photostabilizing silicone fluids
EP2033687B1 (en) * 2007-09-07 2010-10-20 Cutech S.R.L. Compositions comprising pargyline
IL206909A0 (en) 2008-01-11 2010-12-30 Antaria Ltd Mesoporous zinc oxide powder and method for production thereof
BRPI0800085A2 (pt) * 2008-02-08 2009-09-29 Cruz Luis Eduardo Da composição farmacêutica e curativo para tratamento de lesões de pele, bem como uso de sal de cério associado a uma matriz de colágeno
US7780954B2 (en) * 2008-02-19 2010-08-24 Conopco, Inc. Glow and sunless tanning color enhancement by cationic copolymers
US8729108B2 (en) * 2008-06-17 2014-05-20 Christopher J Dannaker Waterborne topical compositions for the delivery of active ingredients such as azelaic acid
EP2275466A1 (de) * 2009-07-16 2011-01-19 Bayer MaterialScience AG Polyharnstoff-basierter Gewebekleber
US8370236B1 (en) 2009-11-24 2013-02-05 Island Intellectual Property Llc Method and system for allocating funds over a plurality of time deposit instruments in depository institutions
US8458089B1 (en) 2010-06-14 2013-06-04 Island Intellectual Property Llc System, method and program product for administering fund movements using depository institution groups
US8583545B1 (en) 2010-09-20 2013-11-12 Island Intellectual Property Llc Systems and methods for money fund banking with flexible interest allocation
CN102229537B (zh) * 2011-05-06 2013-09-25 西南大学 枸橼酸苯海拉明的合成方法
WO2012154903A1 (en) 2011-05-10 2012-11-15 Active Organics, Inc. Compositions containing extracts of mucor miehei and mucor rouxii
US8452702B1 (en) 2011-09-08 2013-05-28 Island Intellectual Property Llc System, method and program product for minimizing fund movements
US8853189B2 (en) 2012-05-31 2014-10-07 Prima Innovations, Llc Antispasmodic 1,2-Diols and 1,2,3-triols
US9174871B2 (en) 2012-11-02 2015-11-03 Empire Technology Development Llc Cement slurries having pyranose polymers
US9238774B2 (en) 2012-11-02 2016-01-19 Empire Technology Development Llc Soil fixation, dust suppression and water retention
WO2014088555A1 (en) 2012-12-04 2014-06-12 Empire Technology Development Llc High performance acrylamide adhesives
US9012402B1 (en) 2014-06-11 2015-04-21 James Blanchard Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation
CA2995431A1 (en) * 2015-08-17 2017-02-23 Aequus Pharmaceuticals Inc. Transdermal delivery of doxylamine succinate and pyridoxine hydrochloride
US10821075B1 (en) 2017-07-12 2020-11-03 James Blanchard Compositions for topical application of a medicaments onto a mammalian body surface

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3834882A (en) * 1972-10-06 1974-09-10 Du Pont Anti-icing gasoline composition
US3920810A (en) 1974-04-23 1975-11-18 Burton Parsons And Company Inc Polyacrylamide containing ophthalmic solutions
US4039501A (en) 1975-05-30 1977-08-02 National Patent Development Corporation Plasticized hydrophilic polymers
US4355028A (en) * 1978-04-04 1982-10-19 Westwood Pharmaceuticals, Inc. Composition for treating acne vulgaris
US4318907A (en) 1978-04-04 1982-03-09 Westwood Pharmaceuticals, Inc. Method for treating acne vulgaris and compositions useful for that purpose
US4954487A (en) * 1979-01-08 1990-09-04 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
JPS596287B2 (ja) 1980-11-28 1984-02-10 日東電工株式会社 医薬製剤
US4434154A (en) * 1981-01-26 1984-02-28 Plough, Inc. Tanning and ultra-violet screening composition having high stability
AU8409582A (en) 1981-06-15 1982-12-23 Alcon Laboratories, Inc. Urea and carboxyvinyl polymers gel compositions
US4478853A (en) * 1982-05-17 1984-10-23 S. C. Johnson & Son, Inc. Skin conditioning composition
US4540568A (en) 1982-10-14 1985-09-10 Trager Seymour F Injectionable viscoelastic ophthalmic gel
US4511366A (en) * 1983-12-16 1985-04-16 Ethyl Petroleum Additives, Inc. Liquid fuels and concentrates containing corrosion inhibitors
GB8401206D0 (en) * 1984-01-17 1984-02-22 Allied Colloids Ltd Polymers and aqueous solutions
GB8414950D0 (en) * 1984-06-12 1984-07-18 Allied Colloids Ltd Cationic polyelectrolytes
US4511367A (en) * 1984-06-13 1985-04-16 Ethyl Corporation Corrosion inhibitors for alcohol containing motor fuel
GB8416453D0 (en) 1984-06-28 1984-08-01 Allied Colloids Ltd Aqueous polymer dispersions
US5017367A (en) 1984-10-01 1991-05-21 Stojkoski Radmila G Skin treatment preparation
US4806345C1 (en) * 1985-11-21 2001-02-06 Johnson & Son Inc C Cross-linked cationic polymers for use in personal care products
GB8531118D0 (en) 1985-12-18 1986-01-29 Allied Colloids Ltd Copolymers
US4731242A (en) * 1986-03-21 1988-03-15 Victor Palinczar Waterproof sunscreen compositions
US4704436A (en) * 1986-05-02 1987-11-03 Barabas Eugene S Water soluble complex of a poly(vinylpyrrolidone) copolymer and α-methyl-(2-methylpropyl)benzene acetic acid
US4837019A (en) 1986-08-11 1989-06-06 Charles Of The Ritz Group Ltd. Skin treatment composition and method for treating burned skin
GB8622797D0 (en) * 1986-09-22 1986-10-29 Allied Colloids Ltd Polymeric particles
ES2061508T3 (es) 1986-10-01 1994-12-16 Allied Colloids Ltd Composiciones polimericas solubles en agua.
US4929577A (en) 1987-03-11 1990-05-29 Medi-Tech International Corporation Transparent wound dressings in sheet form
US4885161A (en) 1987-03-11 1989-12-05 Medi-Tech International Corporation Wound dressings in gelled paste form
KR960011236B1 (ko) * 1987-05-08 1996-08-21 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 제약학적 조성물 및 고체 제형
NZ226171A (en) 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
JPH07116035B2 (ja) 1987-12-08 1995-12-13 塩野義製薬株式会社 被膜形成性抗真菌剤組成物
JPH0749050B2 (ja) 1988-01-18 1995-05-31 久光製薬株式会社 含水ゲル組成物
GB8909095D0 (en) * 1989-04-21 1989-06-07 Allied Colloids Ltd Thickened aqueous compositions
US5009969A (en) * 1989-05-26 1991-04-23 Hi-Tek Polymers, Inc. Dual action sunscreen composition
GB2236760A (en) 1989-10-11 1991-04-17 Inverness Corp Shaving gel
US5043359A (en) * 1990-03-05 1991-08-27 Dow Corning Corporation Skin conditioning compositions containing glyceroxyfunctional silanes and siloxanes
US5162043A (en) * 1990-03-30 1992-11-10 Alza Corporation Iontophoretic delivery device
US5073372A (en) * 1990-11-30 1991-12-17 Richardson-Vicks, Inc. Leave-on facial emulsion compositions
US5221530A (en) 1991-06-24 1993-06-22 Helene Curtis, Inc. Mild conditioning shampoo with a high foam level containing an anionic surfactant-cationic acrylate/acrylamide copolymer conditioning agent
WO1993007902A1 (en) 1991-10-16 1993-04-29 Richardson-Vicks, Inc. Enhanced skin penetration system for improved topical delivery of drugs
MA22677A1 (fr) 1991-10-16 1993-07-01 Richardson Vicks Inc Compositions cosmetiques en gels
US5232688A (en) 1992-06-17 1993-08-03 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Self-tanner cosmetic compositions

Also Published As

Publication number Publication date
HU9401106D0 (en) 1994-07-28
KR100264180B1 (ko) 2000-08-16
CN1072602A (zh) 1993-06-02
FI941770A (fi) 1994-04-15
DE69226369D1 (de) 1998-08-27
NO941317L (no) 1994-06-16
HK1013002A1 (en) 1999-08-13
US6277892B1 (en) 2001-08-21
AU675212B2 (en) 1997-01-30
DK0608322T3 (da) 1998-12-14
BR9206631A (pt) 1995-10-24
ES2118834T3 (es) 1998-10-01
NO941317D0 (no) 1994-04-13
NZ244743A (en) 1995-09-26
JPH07500594A (ja) 1995-01-19
EP0608322A1 (en) 1994-08-03
FI941770A0 (fi) 1994-04-15
JP3471354B2 (ja) 2003-12-02
MX9205937A (es) 1993-05-01
CN1050763C (zh) 2000-03-29
CZ90194A3 (en) 1994-07-13
WO1993007903A1 (en) 1993-04-29
ATE168563T1 (de) 1998-08-15
CA2117265A1 (en) 1993-04-29
DE69226369T2 (de) 1999-02-11
GR3027757T3 (en) 1998-11-30
CA2117265C (en) 2000-08-01
EP0608322B1 (en) 1998-07-22
HUT67046A (en) 1995-01-30
AU2863992A (en) 1993-05-21

Similar Documents

Publication Publication Date Title
EG20380A (en) Enhanced skin penetration system for improved topical delivery of drugs
HU9401107D0 (en) Enhanced skin penetration system for improved topical delivery of drugs
MX9304530A (es) Suministro topico mejorado de farmacos.
NZ262679A (en) Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell
BG101118A (en) Therapeutical compounds
EP1137403A4 (en) A HYDROCOLLOID AND A DELIVERY-RELATED TABLET CONTAINING CELLULOSE ETHER
EP0165696A3 (en) Improved transdermal dosage form
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
CA2173147A1 (en) Anti-obesity agent
EP0620004A4 (en) MEDICAL COMPOSITION.
IL121272A (en) Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
EP0230264A3 (en) Pharmaceutical composition for nasal application, process for its preparation and its use
UA41285C2 (uk) Креатин фосфат і його фармацевтично прийнятні солі для лікування пухлин та фармацевтична композиція, що має протипухлинну активність
SE9403905D0 (sv) New formulations
TR199901237T2 (xx) Bir tienilsiklohegzilamin t�revinin tedavide yeni uygulamas�.
TH13510A (th) ระบบนำส่งยาเฉพาะที่ที่ดีขึ้นซึ่งแทรกซึมผ่านผิวหนังได้เพิ่มขึ้น
PT986390E (pt) Composicoes farmaceuticas que contem cicloridrato de cinchonina
RU94022015A (ru) Композиция, повышающая проникновение через кожу и улучшающая локальное применение лекарств
HUT75711A (en) The use of dimeticone as a transport and carrier system and/or drug delivery system, and pharmaceutical compositions containing dimeticone
FR2759586B1 (fr) Medicament de type anticancereux comportant au moins a titre de principe actif du 1-alpha hydroxycalciferol ou alfacalcidol
RU94019942A (ru) Фармацевтическая композиция для повышения проницаемости кожи для улучшенной локальной доставки лекарств